Nonalcoholic Steatohepatitis
Elevated cadmium levels linked to disease
People with higher levels of cadmium in their urine—evidence of chronic exposure to the heavy metal found in industrial emissions and tobacco smoke—appear to be nearly 3.5 times more likely to die of liver disease than ...
Surgery
May 09, 2013 |
not rated yet |
0
Sunshine hormone, vitamin D, may offer hope for treating liver fibrosis
Liver fibrosis results from an excessive accumulation of tough, fibrous scar tissue and occurs in most types of chronic liver diseases. In industrialized countries, the main causes of liver injury leading ...
Medical research
Apr 25, 2013 |
5 / 5 (1) |
0
|
Dietary medium chain triglycerides prevent nonalcoholic fatty liver disease
Scientists at the Arkansas Children's Nutrition Center, a U.S. Department of Agriculture Agricultural Research Service Human Nutrition Research Center at the University of Arkansas for Medical Sciences, led by Dr. Martin ...
Diseases, Conditions, Syndromes
Apr 24, 2013 |
5 / 5 (1) |
0
Vitamin E identified as potential weapon against obesity
A potential new way to fight obesity-related illness has been uncovered, thanks to serendipitous research led by investigators at the Case Western Reserve University School of Medicine.
Overweight and Obesity
Apr 23, 2013 |
5 / 5 (1) |
0
Cardiovascular issues up mortality rates in patients with advanced fibrosis
New research reveals that advanced fibrosis is a significant predictor of mortality in patients with nonalcoholic fatty liver disease (NAFLD), largely brought about by cardiovascular causes. NAFLD alone was not associated ...
Diseases, Conditions, Syndromes
Apr 10, 2013 |
not rated yet |
0
Some omega-3 oils better than others for protection against liver disease
(Medical Xpress)—Research at Oregon State University has found that one particular omega-3 fatty acid has a powerful effect in preventing liver inflammation and fibrosis – common problems that are steadily rising along ...
Diseases, Conditions, Syndromes
Feb 05, 2013 |
not rated yet |
0
|
New animal model may lead to treatments for common liver disease
Scientists at Texas Biomed have developed the laboratory opossum as a new animal model to study the most common liver disease in the nation – afflicting up to 15 million Americans – and for which there is no cure.
Diseases, Conditions, Syndromes
Jul 03, 2012 |
not rated yet |
0
Researchers identify changes in cholesterol metabolic pathways
A new study from the Virginia Commonwealth University School of Medicine has identified molecular changes responsible for abnormal cholesterol production and metabolism in the livers of patients with a common liver condition, ...
Medical research
Jun 07, 2012 |
not rated yet |
0
Modest alcohol consumption lowers risk and severity of liver disease
People with nonalcoholic fatty liver disease (NALFD) who consume alcohol in modest amounts – no more than one or two servings per day – are half as likely to develop hepatitis as non-drinkers with ...
Addiction
Apr 19, 2012 |
not rated yet |
0
Study identifies genetic variants linked to fatty liver disease in obese children
New research found the genetic variant Patatin-like phospholipase domain containing protein-3 (PNPLA3) acting in conjunction with the glucokinase regulatory protein (GCKR) is associated with increased susceptibility to fatty ...
Genetics
Mar 23, 2012 |
5 / 5 (1) |
0
Coffee consumption reduces fibrosis risk in those with fatty liver disease
Caffeine consumption has long been associated with decreased risk of liver disease and reduced fibrosis in patients with chronic liver disease. Now, newly published research confirms that coffee caffeine consumption reduces ...
Diseases, Conditions, Syndromes
Feb 02, 2012 |
5 / 5 (1) |
0
NIH study to test treatment for fatty liver disease in children
With the launch of a new clinical trial supported by the National Institutes of Health, researchers are working to determine whether treating children diagnosed with the most severe form of fatty liver disease with a drug ...
Diseases, Conditions, Syndromes
Jan 12, 2012 |
not rated yet |
0
High rates of disability and health care use for older Americans with cirrhosis
New research shows that older Americans with cirrhosis have significantly worse health status and greater functional disability compared to those without this potentially deadly disease. In fact, findings now published in ...
Diseases, Conditions, Syndromes
Jan 10, 2012 |
not rated yet |
0
Obesity and diabetes epidemics spur increase in nonalcoholic steatohepatitis
Nonalcoholic steatohepatitis (NASH) occurs when fat builds up in the liver. This accumulation of fat damages the liver and leads to cirrhosis. NASH is rapidly increasing in the U.S. mainly related to the epidemics of obesity ...
Diseases, Conditions, Syndromes
Dec 14, 2011 |
not rated yet |
0
Vitamin E or metformin may not be effective for treating liver disease in children and teens
In contrast to previous preliminary data, use of vitamin E or the diabetes drug metformin was not superior to placebo on a measured outcome for treating nonalcoholic fatty liver disease in children and adolescents, according ...
Diseases, Conditions, Syndromes
Apr 26, 2011 |
4 / 5 (1) |
0
|
- Pages: 1
Non-alcoholic fatty liver disease (NAFLD) is one cause of a fatty liver, occurring when fat is deposited (steatosis) in the liver not due to excessive alcohol use. It is related to insulin resistance and the metabolic syndrome and may respond to treatments originally developed for other insulin-resistant states (e.g. diabetes mellitus type 2) such as weight loss, metformin and thiazolidinediones. Non-alcoholic steatohepatitis (NASH) is the most extreme form of NAFLD this being regarded as a major cause of cirrhosis of the liver of unknown cause.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
Latest Spotlight News
A molecular explanation for age-related fertility decline in women
(Medical Xpress)—Scientists supported by the National Institutes of Health have a new theory as to why a woman's fertility declines after her mid-30s. They also suggest an approach that might help slow ...
Medical researchers discover new ways to target, develop and design drugs to prevent and treat viral infection
Researchers at the University of Alberta have discovered a new drug target, developed a new drug and identified a new way to design drugs—all of which could be a winning combination in the battle against viruses.
Study says empathy plays a key role in moral judgments
Is it permissible to harm one to save many? Those who tend to say "yes" when faced with this classic dilemma are likely to be deficient in a specific kind of empathy, according to a report published in the scientific journal ...
Phthalates: Study links chemicals widely found in plastics, processed food to elevated blood pressure in children, teens
Plastic additives known as phthalates (pronounced THAL-ates) are odorless, colorless and just about everywhere: They turn up in flooring, plastic cups, beach balls, plastic wrap, intravenous tubing and—according to the ...
If you can remember it, you can remember it wrong
(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...
B vitamins could delay dementia
(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...
Insight into the dazzling impact of insulin in cells
Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.
Reducing caloric intake delays nerve cell loss
Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...
New sleeping pill poised to hit US markets
An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.
Antidepressant reduces stress-induced heart condition
A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.
